Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale
B. Galindo-Mendez(Harvard University), Vera Novak(Beth Israel Deaconess Medical Center), Jorge A. Trevino(Harvard University), Catherine B. Fortier(Boston University), Regina E. McGlinchey, Long Ngo(Beth Israel Deaconess Medical Center), Christos S. Mantzoros(Harvard University), Vasileios Lioutas(Beth Israel Deaconess Medical Center), Péter Novák(Brigham and Women's Hospital)
Cited by 28
Related Papers
The Boston Assessment of Traumatic Brain Injury–Lifetime (BAT-L) Semistructured Interview
|Journal of Head Trauma Rehabilitation|2013|186
Opioid utilization and opioid‐related adverse events in nonsurgical patients in US hospitals
|Journal of Hospital Medicine|2013|171
Deployment‐Related Psychiatric and Behavioral Conditions and Their Association with Functional Disability in OEF/OIF/OND Veterans
|Journal of Traumatic Stress|2015|158
Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses
|Cell Reports Medicine|2023|141
A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: The TRACTS longitudinal prospective cohort study
|International Journal of Methods in Psychiatric Research|2017|138